Concepedia

Omotayo Arowojolu

OA

4

Publications

282

Citations

4

H-Index

2008

Active since

Affiliations

Sidney Kimmel Comprehensive Cancer Center(Current)

Omotayo Arowojolu is an author at Sidney Kimmel Comprehensive Cancer Center specializing in tumor biology, signal transduction, and cell signaling.

ORCID

Top concepts

Publications per year

2008–2017

4

Publications

4

A pharmacodynamic study of the FLT3 inhibitor KW-2449 yields insight into the basis for clinical response

Keith W. Pratz, Jörge E. Cortes, Gail J. Roboz et al. · Blood · 2008 · 182 citations · Full text

A potential therapeutic target for FLT3-ITD AML: PIM1 kinase

Amir T. Fathi, Omotayo Arowojolu, Ian Swinnen et al. · Leukemia Research · 2011 · 56 citations · Full text

, , +6

The nuclear factor (erythroid‐derived 2)‐like 2 (<scp>NRF</scp>2) antioxidant response promotes melanocyte viability and reduces toxicity of the vitiligo‐inducing phenol monobenzone

Omotayo Arowojolu, Seth J. Orlow, Nada Elbuluk et al. · Experimental Dermatology · 2017 · 28 citations · Full text

The Novel Inhibitor PLX3397 Effectively Inhibits FLT3-Mutant AML,

Elizabeth A. Burton, Bernice H. Wong, Jiazhong Zhang et al. · Blood · 2011 · 16 citations

Rows per page

1–4 of 4